Literature DB >> 17896292

Open-angle glaucoma -- an epidemiologic overview.

M Cristina Leske1.   

Abstract

PURPOSE: To provide a summary overview of current epidemiologic data on open-angle glaucoma.
METHODS: Literature review.
RESULTS: The review summarizes information on the following topics: Definition of open-angle glaucoma; Prevalence data from studies conducted in various populations; Incidence data available from population studies; Risk factors, categorized as demographic, familial, systemic, and ocular; and, Progression factors. It concludes by outlining the epidemiologic contributions to glaucoma and suggesting research needs.
CONCLUSIONS: Epidemiologic studies have contributed greatly to our knowledge of open-angle glaucoma. Still, many gaps remain, and the multifactorial etiology of glaucoma needs further clarification. Future research would benefit by standardizing the approach to define the disease, thus allowing better comparability across studies. A major priority is to achieve a better understanding of risk factors, which are likely to involve gene-environment interactions.

Entities:  

Mesh:

Year:  2007        PMID: 17896292     DOI: 10.1080/09286580701501931

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  76 in total

1.  In vivo optic nerve head biomechanics: performance testing of a three-dimensional tracking algorithm.

Authors:  Michaël J A Girard; Nicholas G Strouthidis; Adrien Desjardins; Jean Martial Mari; C Ross Ethier
Journal:  J R Soc Interface       Date:  2013-07-24       Impact factor: 4.118

Review 2.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

3.  Noninvasive measurement of wave speed of porcine cornea in ex vivo porcine eyes for various intraocular pressures.

Authors:  Boran Zhou; Arthur J Sit; Xiaoming Zhang
Journal:  Ultrasonics       Date:  2017-06-07       Impact factor: 2.890

Review 4.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

5.  Relationship among visual field, blood flow, and neural structure measurements in glaucoma.

Authors:  John C Hwang; Ranjith Konduru; Xinbo Zhang; Ou Tan; Brian A Francis; Rohit Varma; Mitra Sehi; David S Greenfield; Srinivas R Sadda; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

Review 6.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

Review 7.  Vascular considerations in glaucoma patients of African and European descent.

Authors:  Andrew Huck; Alon Harris; Brent Siesky; Nathaniel Kim; Michael Muchnik; Priyanka Kanakamedala; Annahita Amireskandari; Leslie Abrams-Tobe
Journal:  Acta Ophthalmol       Date:  2014-01-25       Impact factor: 3.761

8.  Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension.

Authors:  Nicholas P Bell; José L Ramos; Robert M Feldman
Journal:  Clin Ophthalmol       Date:  2010-11-22

9.  Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.

Authors:  Xiaolei Wang; Chunhui Jiang; Tony Ko; Xiangmei Kong; Xiaobo Yu; Wang Min; Guohua Shi; Xinghuai Sun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-11       Impact factor: 3.117

10.  AQP1 and SLC4A10 as candidate genes for primary open-angle glaucoma.

Authors:  Wenjing Liu; Yutao Liu; Xue-Jun Qin; Silke Schmidt; Michael A Hauser; R Rand Allingham
Journal:  Mol Vis       Date:  2010-01-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.